Norge -
norsk -
Statens legemiddelverk
silkis 3 mikrog/ g
galderma nordic ab - kalsitriol - salve - 3 mikrog/ g
Norge -
norsk -
Statens legemiddelverk
rocaltrol 0.25 mikrog
atnahs pharma netherlands b.v. - kalsitriol - kapsel, myk - 0.25 mikrog
Norge -
norsk -
Statens legemiddelverk
rocaltrol 0.25 mikrog
2care4 aps - kalsitriol - kapsel, myk - 0.25 mikrog
Norge -
norsk -
Statens legemiddelverk
rocaltrol 0.25 mikrog
2care4 aps - kalsitriol - kapsel, myk - 0.25 mikrog
Norge -
norsk -
Statens legemiddelverk
rocaltrol 0.25 mikrog
2care4 aps - kalsitriol - kapsel, myk - 0.25 mikrog
Den europeiske union -
norsk -
EMA (European Medicines Agency)
crysvita
kyowa kirin holdings b.v. - burosumab - hypophosphatemia, familial; hypophosphatemic rickets, x-linked dominant; osteomalacia - legemidler til behandling av bein sykdommer - crysvita is indicated for the treatment of x-linked hypophosphataemia, in children and adolescents aged 1 to 17 years with radiographic evidence of bone disease, and in adults. crysvita is indicated for the treatment of fgf23-related hypophosphataemia in tumour-induced osteomalacia associated with phosphaturic mesenchymal tumours that cannot be curatively resected or localised in children and adolescents aged 1 to 17 years and in adults.
Norge -
norsk -
Statens legemiddelverk
normorix mite 25 mg / 2.5 mg
orifarm healthcare a/s - hydroklortiazid / amiloridhydroklorid - tablett - 25 mg / 2.5 mg
Norge -
norsk -
Statens legemiddelverk
etalpha 2 mikrog/ ml
cheplapharm arzneimittel gmbh - alfakalsidol - dråper, oppløsning - 2 mikrog/ ml
Norge -
norsk -
Statens legemiddelverk
etalpha 0.25 mikrog
cheplapharm arzneimittel gmbh - alfakalsidol - kapsel, myk - 0.25 mikrog
Norge -
norsk -
Statens legemiddelverk
etalpha 0.5 mikrog
cheplapharm arzneimittel gmbh - alfakalsidol - kapsel, myk - 0.5 mikrog